Ligo Biosciences logo

Ligo BiosciencesGenerative enzyme design for the chemical industry.

We are building the next generation of deep-learning models for enzyme design to slash the cost of chemical manufacturing. The $6 trillion chemical industry is flawed: It produces 20% of industrial greenhouse gases, and is responsible for 15% of global energy usage. Enzymes offer a far more sustainable alternative to chemical synthesis and have already revolutionised how a select few chemicals are produced. The problem is each enzyme takes years of trial and error to develop. Our enzyme models learn the principles of catalysis, allowing us to design enzymes for each reaction, in days not years.

2024-08-09
Active
Early
S24
3
Healthcare
United States of AmericaAmerica / Canada
Ligo Biosciences screenshot
More About Ligo Biosciences

Ligo Biosciences: Catalysing Change in the Chemical Industry

Introduction

Ligo Biosciences leverages generative diffusion models for enzyme design, offering higher precision, stability, and activity. Our cutting-edge technology is set to revolutionize industries such as pharmaceuticals, detergents, fragrances, and agricultural chemical manufacturing.

Key Features

  • Generative Diffusion Models: Advanced models with spatial understanding for precise enzyme design.
  • Reaction Selection: Optimal enzymatic pathways evaluated for each reaction.
  • Enzyme Modelling: In-house tools for detailed enzyme-ligand structure modeling.
  • Ligo AI: Integration of structural and evolutionary data for superior enzyme design.
  • Single Shot Enzyme Design: New diffusion model generating enzymes from transition states.

Use Cases

  • Agriculture: Redesigning enzymes like phytase to enhance animal feed phosphate content.
  • Biomining: Developing enzymes to extract precious minerals like lithium from ores.
  • Carbon Capture: Engineering enzymes to improve biological carbon capture technologies.
  • Pharmaceutical Manufacturing: Creating enzymatic cascades for APIs, reducing cost and time.

Pricing

Our pricing model is tailored to the specific needs of each industry and project. Contact us for a detailed quote and to discuss how our enzyme design technology can benefit your business.

Teams

  • Edward Harris, CEO: A Princeton and Oxford-trained expert in computer science and biology, with a background in genetic engineering and computational modeling.
  • Emily Egerton-Warburton, CSO: A top-ranked biochemist from Oxford University, experienced in strain engineering and chemostasis experiments.
  • Arda Goreci, CTO: A proficient coder and co-founder, leading our technological advancements.

Ligo Biosciences is committed to creating economic and environmental value through innovative enzyme technology. Join us in catalyzing change in the chemical industry.